The trademark application GalOmic was filed by E-THERAPEUTICS PLC, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on October 16, 2023, and it was registered by office on January 23, 2024 without any oppositions.
The application was filed in English (German was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on October 29, 2024.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical and medical preparations for use in targeting genes and silencing or inhibiting gene expression
Drug delivery agents that facilitate the delivery of pharmaceutical preparations targeting genes and silencing or inhibiting gene expression
Drug delivery agents that facilitate the delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticals, and nucleic acid-based drugs (NABDs)
Drug delivery agents that facilitate the delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticals, and nucleic acid-based drugs (NABDs), all for targeting genes and silencing or inhibiting gene expression
RNAi-based medicines and pharmaceuticals
Short interfering RNA-based (siRNA) medicines and pharmaceuticals
Nucleic acid-based drugs (NABDs)
Pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation.
The mark was filed in class 9 with following description of goods:
Computer software for use in the field of pharmaceuticals, medicines and drug delivery
Computer software for facilitating the targeted delivery of pharmaceutical and medical preparations
Computer software for facilitating the targeted delivery of pharmaceutical and medical preparations for silencing or inhibiting gene expression
Computer software for facilitating the targeted delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticals, and nucleic acid-based drugs (NABDs)
Artificial intelligence and machine learning software for use in the field of pharmaceuticals, medicines and drug delivery
Artificial intelligence and machine learning software for facilitating the delivery of pharmaceutical and medical preparations
Artificial intelligence and machine learning software for facilitating the delivery of pharmaceutical and medical preparations targeting genes and silencing or inhibiting gene expression
Artificial intelligence and machine learning software for facilitating the delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticals, and nucleic acid-based drugs (NABDs)
Artificial intelligence and machine learning software for facilitating the delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticals, and nucleic acid-based drugs (NABDs), all for targeting genes and silencing or inhibiting gene expression
Electronic databases for use in the field of pharmaceuticals, medicines and drug delivery
Electronic databases for use in the field of gene therapy
Electronic databases for use in the field of gene therapy, namely, the delivery of pharmaceutical and medical preparations
Electronic databases for use in the field of gene therapy, namely, the delivery of pharmaceutical and medical preparations targeting and silencing or inhibiting of genes
Electronic databases for use in the field of gene therapy, namely, the delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticals, and nucleic acid-based drugs (NABDs)
Computer platform software for use in the field of pharmaceuticals, medicines and drug delivery
Computer software platforms for use in the field of pharmaceuticals, medicines and drug delivery
Computer software enabling the searching and retrieval of data relating to pharmaceuticals, medicines and drug discovery
Software for the analysis of data relating to pharmaceuticals, medicines and drug discovery
Search engine software for use in the field of pharmaceuticals, medicines and drug discovery
Search engine software for the searching, retrieval, indexing and analysis of data relating to pharmaceuticals, medicines and drug discovery.
The mark was filed in class 40 with following description of goods:
Custom manufacture of pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression
Custom manufacture of RNAi-based pharmaceuticals and medicines
Custom manufacture of short interfering RNA (siRNA) medicines
Custom manufacture of nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression
Custom manufacture of pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation
Provision of information, advice and consultancy services relating to all of the aforesaid.
The mark was filed in class 42 with following description of goods:
Scientific research and development in the field of targeting genes and blocking, silencing or inhibiting gene expression
Scientific, pharmaceutical and medical research and development services relating to RNAi-based pharmaceuticals and medicines
Scientific, pharmaceutical and medical research and development services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression
Scientific, pharmaceutical and medical research and development services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking gene expression, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and, pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation
Drug discovery services relating to RNAi-based pharmaceuticals and medicines
Drug discovery services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression
Drug discovery services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation
Scientific and technical data analysis in relation to pharmaceuticals and medicines
Scientific and technical data analysis in relation to RNAi-based medicines
Scientific and technical data analysis in relation to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression
Scientific and technical data analysis in relation to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation
Design, development, creation and maintenance of computer platforms and computer software for use in the field of pharmaceuticals, medicines and drug discovery
Design, development, creation and maintenance of computer platforms and computer software enabling the searching and retrieval of data relating to pharmaceuticals, medicines and drug discovery
Design, development, creation and maintenance of computer platforms and computer software for the analysis of data relating to pharmaceuticals, medicines and drug discovery
Design, provision and operation of search engine software for use in the field of pharmaceuticals, medicines and drug discovery
Design, provision and operation of search engine software for the searching, retrieval, indexing and analysis of data relating to pharmaceuticals, medicines and drug discovery
Platform as a Service (PaaS) services relating to the use of artificial intelligence and machine learning software and databases in the field of pharmaceuticals, medicines and drug discovery
Platform as a Service (PaaS) services relating to the use of artificial intelligence and machine learning software and databases in relation to RNAi-based medicines and pharmaceuticals, short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation
Design and development of computer-simulated models for use in the field of pharmaceuticals, medicines and drug discovery
Providing non-downloadable computer software for use in the field of pharmaceuticals, medicines and drug discovery
Software as a Service (SaaS) services relating to the use of artificial intelligence and machine learning software and databases in the field of pharmaceuticals, medicines and drug discovery
Software as a Service (SaaS) services relating to the use of artificial intelligence and machine learning in relation to RNAi-based medicines and pharmaceuticals, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation
Provision of information, advice and consultancy services relating to all of the aforesaid.